Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $TBP.V, CSE: $GLH.C, OTCQB: $GSRX, TSXV: $ABCN.V, OTC: $ADYNF
August 3rd Potcast sponsored by Lexaria Bioscience Corp. (CSE: $LXX.C) (OTC: $LXRP) a #Cannabis company with a new disruptive drug delivery platform: DehydraTECH
Delta, Kelowna, BC - August 3, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: TBP, CSE: GLH, OTCQB: GSRX, TSXV: ABCN, OTC: ADYNF
Today's podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast - looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today's potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on the OTC as LXRP. Lexaria has developed a new disruptive drug delivery platform: DehydraTECH The Company's patented technology changes the way Active Pharmaceutical Ingredients ("APIs") enter the body orally:
1) Masks unwanted tastes - eliminates the need for sugar-filled edibles.
2) Reduces time of onset - effects are felt within 15-20 min vs. 60-120 min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company's DehydraTECH™ technology is patent-protected for multiple APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble vitamins.
Learn more about Lexaria at www.lexariabioscience.com
Today's podcast features news from Tetra Bio-Pharma Inc. trading on the TSX-VENTURE as TBP and the OTCQB as TBPMF, Golden Leaf Holdings Ltd. trading on the CSE as GLH and the OTCQB as GLDFF, GSRX Industries Inc. trading on the OTCQB as GSRX, ABcann Global Corporation trading on the TSX-Venture as ABCN and OTCQB as ABCCF and ALGAE DYNAMICS CORP trading on the OTC as ADYNF.
Tetra Bio-Pharma Inc., a leader in cannabinoid-based drug discovery and development, today announced that the company has provided an extension to North Bud Farms Inc. Tetra and North Bud Farms Inc. are working diligently to finalize the transaction and to this end Tetra Bio-Pharma has agreed to provide an extension to North Bud Farms Inc. with regards to the final receipt of North Bud's prospectus'. As one of the closing conditions to the sale these documents must now be submitted by August 31, 2018. Upon final receipt of North Bud's prospectus and meeting the requirements requested by the Ontario Securities Commission, Tetra will announce the record date and begin the process with the distribution of the dividend which must be finalized before listing the shares of North Bud Farms Inc.
Golden Leaf Holdings Ltd., a cannabis company with cultivation, production and retail operations built around recognized brands, today announced its upcoming attendance at a number of major cannabis industry and investor events.
From August 8 to 9, Golden Leaf CEO William Simpson will present at the Canaccord Genuity's 38th Annual Growth Conference taking place in Boston, Massachusetts. The Canaccord conference is a premier investment forum for innovative small and mid-cap growth companies from the U.S., Canada, and the U.K.
Later in the month, management will attend MJBIZCon Int'l in Toronto, Ontario from August 14 to 16 as well as CEO William Simpson will also present at the Benzinga Cannabis Capital Conference from August 16 to 17 in Toronto.
Simpson said, "Attending industry conferences and events provides extremely valuable insight into the health of the industry as a whole and the strategies, products and innovations that will shape the months and years to come. They are important opportunities to interact with potential investors, media, and industry leaders and to discuss the most critical topics impacting cannabis today."
GSRX Industries Inc., through its wholly-owned subsidiary, Project 1493 LLC, announced today that it has received pre-qualification and preliminary approval for a medicinal cannabis transportation license in Puerto Rico. This is in addition to the eight dispensary pre-qualifications it has received to date, as well as pre-qualification for a medicinal cannabis manufacturing license recently received. Of its pre-qualified dispensary locations, Green Spirit RX dispensaries are currently operating in Dorado, Carolina, and San Juan (Hato Rey), with five locations in various stages of development and construction in Fajardo, Isla Verde, San Juan (Andalucia), Bayamón, and Old San Juan.
The pre-qualified transportation license allows GSRX to transport and deliver cannabis between authorized dispensaries and patients' homes in Puerto Rico. Start of medicinal cannabis delivery by GSRX in Puerto Rico is dependent upon numerous factors and will begin only after the pre-qualified business undergoes requisite inspections and is issued all requisite permits and licensing from the Puerto Rico Department of Health.
ABcann Global Corporation announced that, effective immediately, it will be known as VIVO Cannabis Inc. — a contemporary reflection of the Company's evolution, purpose and direction. The name change became effective at market open today and "VIVO" will replace "ABCN" as the Company's ticker symbol on the TSX Venture Exchange.
VIVO — which translates to "living" in Latin — embodies the Company's commitment to providing quality cannabis products and services that improve lives. It's the common thread that unites us all, and it's the spirit behind the rebranding. It also celebrates the recent announcement of the Company's proposed acquisition of Canna Farms Limited.
ALGAE DYNAMICS CORP , a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, today announced it has received funding of CDN$520,000 through the sale of $100,000 Canadian 10% Convertible Debentures (convertible into 400,000 shares of common stock at $0.25 CAN) and $420,000 CAN through the sale of 1,050,000 shares of restricted Common stock at $0.40 CAN and the issuance of 525,000 purchase warrants at $0.75 CAN via an Offering Memorandum from accredited investors.
The Company intends to use the funds to further support Dr. Steven Laviolette and his team at Western University and Dr. Jonathan Blay at The University of Waterloo (announced previously).
Funds will also be allocated for patent applications, supporting development activities with their Licensed Partners, general administrative expenses and compliance.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria's technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Follow us on Social Media
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing